Trials / Terminated
TerminatedNCT02183233
Efficacy and Safety of Eschscholtzia Californica in Treating Primary Insomnia
A Double-blind Randomized, Placebo Controlled Study to Assess the Efficacy and the Safety of Eschscholtzia Californica 1000 mg Per Day in Treating Primary Insomnia During a 28 Day Treatment Duration.
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 49 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this trial was to assess the efficacy and safety of Eschscholtzia Californica (EC) in treating patients having psycho-physiologic insomnia in a double-blind randomised placebo controlled trial during a 28-day treatment duration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Eschscholtzia Californica | |
| DRUG | Eschscholtzia Californica Placebo |
Timeline
- Start date
- 1998-01-01
- Primary completion
- 1998-06-01
- First posted
- 2014-07-08
- Last updated
- 2014-07-08
Source: ClinicalTrials.gov record NCT02183233. Inclusion in this directory is not an endorsement.